Delivery Order SPE2DB20D7059-SPE2DB25FQBG9

Award Date 3/6/25
Potential Completion Date 3/7/25
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order with a firm fixed price valued at $1,167.18, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of 4,565,749,812 units of Levothyroxine 50 MCG Tablets, a medication used to treat hypothyroidism. The ultimate completion date for this delivery order is September 11, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
This federal contract award, valued at $1,353.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order to supply Levothyroxine 100 mcg vials, a critical medication, to support military healthcare programs. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,323.52, is for the delivery of 1,000 units of the medication Levothyroxine 112 MCG Tablet. The contract has a firm fixed price and is scheduled for completion by September 15, 2023. The award was made on September 14, 2023, and there was no set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Levothyroxine 137 MCG Tablets in 1,000-count quantities, with a ceiling value of $1,617.60 and a performance period through October 31, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB25D3003|SPE2DB25FPVTQ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Levothyroxine 112 MCG Capsules in 30-count packages, with a ceiling value of $1,042.29 and a performance period ending on February 11, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,271.02, is for the delivery of 4,564,817,264 units of Levothyroxine 137 MCG Tablets in 1,000 count bottles. The contract has a completion date of June 6, 2024 and uses a Firm Fixed Price pricing structure. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,697.45 delivery order is for the supply of levothyroxine 100 mcg vials, with a completion date of September 7, 2022. The contract is a firm fixed-price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
The Defense Logistics Agency (DLA) awarded a $1,092.69 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,563,189,790 units of 112 mcg Levothyroxine tablets. This contract, with an ultimate completion date of December 28, 2023, is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that specializes in supplying a wide range of medical products, including specialty medications,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Levothyroxine 100 MCG vials. The $8,998.25 firm fixed price delivery order was awarded on March 16, 2022, with a completion date of March 17, 2022. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,556,604,296 vials of the medication Levothyroxine 100 MCG. The contract has a ceiling value of $3,583.33 and a period of performance through March 18, 2022. This is a delivery order contract with a firm fixed price pricing type. No set-aside designation is...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FQBG9
    Delivery Order

This federal contract award, valued at $8,598.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the drug Levothyroxine 125 mcg tablets, a medication used to treat thyroid disorders.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating it was awarded through open competition. Amerisourcebergen is the prime contractor, and the contract has an ultimate completion date of March 7, 2025.

Generated 6/5/25, 10:09 AM